Helius Medical Technologies Files 8-K
Ticker: HSDT · Form: 8-K · Filed: Dec 23, 2024 · CIK: 1610853
| Field | Detail |
|---|---|
| Company | Helius Medical Technologies, Inc. (HSDT) |
| Form Type | 8-K |
| Filed Date | Dec 23, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $23,844, $16,499, $7,345 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, disclosure
TL;DR
Helius Medical filed an 8-K with financial statements and exhibits. No major news.
AI Summary
On December 23, 2024, HELIUS MEDICAL TECHNOLOGIES, INC. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclosure rather than a specific event like an acquisition or major business change. No specific dollar amounts or new strategic initiatives were detailed in the provided excerpt.
Why It Matters
This filing serves as a public record of Helius Medical Technologies' financial statements and exhibits, providing transparency to investors and stakeholders.
Risk Assessment
Risk Level: low — The filing appears to be a routine disclosure of financial statements and exhibits, with no immediate indication of significant positive or negative events.
Key Players & Entities
- HELIUS MEDICAL TECHNOLOGIES, INC. (company) — Registrant
- December 23, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for HELIUS MEDICAL TECHNOLOGIES, INC.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of December 23, 2024.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is December 23, 2024.
In which state is HELIUS MEDICAL TECHNOLOGIES, INC. incorporated?
HELIUS MEDICAL TECHNOLOGIES, INC. is incorporated in Delaware.
What is the company's principal executive office address?
The company's principal executive office is located at 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940.
Does this filing indicate any specific new business developments or financial results?
Based on the provided excerpt, the filing indicates 'Other Events' and 'Financial Statements and Exhibits,' suggesting a routine disclosure rather than specific new business developments or detailed financial results.
Filing Stats: 468 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-12-23 09:00:39
Key Financial Figures
- $0.001 — hich registered Class A Common Stock, $0.001 par value HSDT The Nasdaq Stock Mar
- $23,844 — ervices, was at the contracted price of $23,844, comprised of $16,499 for the PoNS Cont
- $16,499 — ntracted price of $23,844, comprised of $16,499 for the PoNS Controller and $7,345 for
- $7,345 — of $16,499 for the PoNS Controller and $7,345 for the PoNS Mouthpiece. The full text
Filing Documents
- hsdt-20241223x8k.htm (8-K) — 41KB
- hsdt-20241223xex99d1.htm (EX-99.1) — 16KB
- hsdt-20241223x8k001.jpg (GRAPHIC) — 7KB
- hsdt-20241223xex99d1001.jpg (GRAPHIC) — 8KB
- 0001558370-24-016446.txt ( ) — 210KB
- hsdt-20241223.xsd (EX-101.SCH) — 3KB
- hsdt-20241223_lab.xml (EX-101.LAB) — 16KB
- hsdt-20241223_pre.xml (EX-101.PRE) — 10KB
- hsdt-20241223x8k_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On December 23, 2024, Helius Medical Technologies, Inc. (the "Company") announced the first PoNS System sale to the VA Healthcare System. The PoNS System sale through our distributor, Lovell Government Services, was at the contracted price of $23,844, comprised of $16,499 for the PoNS Controller and $7,345 for the PoNS Mouthpiece. The full text of the press release issued in conjunction with the announcement is included in Exhibit 99.1 to this Current Report on Form 8-K.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Company Press Release dated December 23, 2024 . 104 Cover Page Interactive Data File (embedded within Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HELIUS MEDICAL TECHNOLOGIES, INC. Dated: December 23, 2024 By: /s/ Jeffrey S. Mathiesen Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary 3